COURSE 77:

ASSESSING POSITIVE AND NEGATIVE SYMPTOMS IN PSYCHOSIS WITH THE PANSS

Co-Directors: Lewis A. Opler, M.D., Paul M. Ramirez, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify positive and negative general psychopath psychotic symptoms and (2) utilize the Structured Clinical Interview (SCI-PANSS) and Informant Questionnaire (IQ-PANSS) to accurately use the Positive and Negative Syndrome Scale (PANSS) in rating SXS. Course Level: This is an intermediate course. Participants should have some experience in diagnosing schizophrenia and other psychoses. This is a repeat of a course given last year. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 25.

COURSE 78:

BIOETHICS UPDATE 2004

Director: Edmund G. Howe, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) use four different approaches to resolve ethics conflicts; (2) know practical salutations to ethical dilemmas involving competent and incompetent patients; and (3) know current consensus & controversies in bioethics, including those in fetal surgery and in the interrogation of captured terrorists. Course Level: This is a basic course. No knowledge of bioethics is necessary. This is a revision of a course given last year. Wed, May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 25.

COURSE 79:

PSYCHIATRIC CONSULTATION IN LONG-TERM CARE

Director: George T. Grossberg, M.D. Faculty: Judith H.W. Crossett, M.D., Abhilash K. Desai, M.D. Educational Objective: At the conclusion of this course, the participant will know (1) the epidemiology of mental disorders in long-term-care residents and process of consultation, including reimbursement issues and OBRA regulations and (2) various etiologies of behavioral disturbances and management using appropriate pharmacologic and nonpharmacologic interventions. Course Level: This is a basic course. No previous experience or knowledge is required. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 80:

INSANITY DEFENSE EVALUATIONS

Director: Phillip J. Resnick, M.D. Educational Objective: At the conclusion of this course, the participant should be able to systematically evaluate criminal defendants and formulate well-reasoned opinions about criminal responsibility. Course Level: This is a basic course. No previous experience or knowledge is required. This is a repeat of a course given last year. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 40.

COURSE 81:

CONTEMPORARY MALPRACTICE LIABILITY: A PRACTICAL GUIDE

Co-Directors: Eugene L. Lowenkopf, M.D., Abe Rychik, J.D. Faculty: Richard G. Hersh, M.D., Jacqueline M. Melonas, J.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand the procedures involved in medical malpractice suits; (2) participate more effectively within the legal system; (3) know the relevant legal issues in managed care and shared treatment of BPD; and (4) utilize risk management more effectively. Course Level: This is a basic course. No prior experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 82:

PSYCHIATRY IN JAIL

Directors: Ole J. Thienhaus, M.D. Faculty: Melissa P. Piasecki, M.D., Jan Budetti, M.S.W., John N. Chappel, M.D., Richard Horton, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand (1) inter alia, advocacy conflicts inherent in the conditions of institutional employment of health professionals; (2) the challenges of limited treatment armamentaria; and (3) issues of patient autonomy in a setting where compliance is rewarded by the system’s social norms. Course Level: This is a basic course. No prior experience or knowledge is required. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 83:

HELPING PARENTS FROM THE INSIDE OUT: ATTACHMENT, MINDSIGHT, AND THE BRAIN

Director: Daniel J. Siegel, M.D. Faculty: Mary Hartzell, M.Ed. Educational Objective: At the conclusion of this course, the participant should be able to demonstrate an understanding of how parents’ self-understanding and capacity to reflect on the mind enable them to provide their children with security of attachment. Skills will be acquired that enable therapists to promote mindsight in parents that promotes coherent self-understanding and secure attachments in their children. Course Level: This is a basic course. No prior experience or knowledge is required. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 84:

INFANTICIDE: A DIALOGUE BETWEEN THE PSYCHIATRIST AND THE ATTORNEY

Co-Directors: Margaret G. Spinelli, M.D., Katherine L. Wisner, M.D. Faculty: George Parnham, J.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) provide a framework for early identification and treatment of women at risk; (2) assist psychiatrists who face the challenges of the criminal court system; (3) provide a basis for liaison between the legal system and mental health; (4) know what to learn from the attorney about the court; (5) know what to teach the attorney about psychiatric diagnosis; and (6) emphasize the need for formal diagnostic guidelines in DSM for postpartum disorders. Course Level: This is a basic course. No prior experience or knowledge is required. Wed., May 5, 8-12; Hilton New York; fee: advance $100, on site $130; spaces available: 100.

COURSE 85:

OFFICE-BASED BUPRENORPHINE TREATMENT OF OPIOID-DEPENDENT PATIENTS

Co-Directors: Thomas R. Kosten, M.D., Eric C. Strain, M.D. Faculty: Walter Ling, M.D., Laura F. McNicholas, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify the clinically relevant pharmacological characteristics of buprenorphine; (2) describe the resources needed to set up office-based treatment with buprenorphine for patients with opioid dependence; and (3) list at least five factors to consider in determining whether the patient is an appropriate candidate for office-based treatment with buprenorphine. Course Level: This is an intermediate course. Participants should have basic knowledge of diagnosis and treatment of patients with substance abuse disorders. This is a repeat of a course given last year. Wed., May 5, 8-5; Hilton New York; fee: advance $200, on site $260; spaces available: 100.

COURSE 86:

PSYCHOTHERAPY OF BORDERLINE PERSONALITY

Co-Directors: Otto F. Kernberg, M.D., Frank E. Yeomans, M.D. Faculty: John F. Clarkin, Ph.D., Eve Caligor, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand the basic concepts and techniques of effective psychotherapy for borderline patients, including object-relations theory; the treatment contract; and the strategies, tactics, and techniques of therapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 9-4; Hilton New York; fee: advance $160, on site $185; spaces available: 75.

COURSE 87:

THE NEUROENDOCRINOLOGY OF MOOD DISORDERS

Co-Directors: Mark A. Frye, M.D., Natalie L. Rasgon, M.D. Faculty: D. Jeffrey Newport, M.D., Michael Bauer, M.D., Catherine A. Roca, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) better understand the neurobiology of each endocrine axis in depression and (2) potential treatment options with hormonal therapy. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 9-4; Hilton New York; fee: advance $160, on site $185; spaces available: 100.

COURSE 88:

MONEY MATTERS II: ADVANCED CLINICAL PRACTICE

Director: Cecilia M. Mikalac, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify many monetary transferences and countertransferences; (2) use psychodynamic theory to deal with nonpayment and impasses over payment; and (3) hone payment policies to forward treatment. Course Level: This is an intermediate course. Participation in the Money Matters I course or five years of clinical experience is required. Wed., May 5, 9-4; Hilton New York; fee: advance $160, on site $185; spaces available: 25. An introductory course on this topic will be offered on Mon., May 3, 9-4. See Course 41 for details.

COURSE 89:

INTRODUCTION TO COGNITIVE-BEHAVIORAL THERAPY

Co-Directors: Robert M. Goisman, M.D., Philip G. Levendusky, Ph.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) recognize clinical problems responsive to cognitive-behavioral methods, and (2) describe the cognitive-behavioral treatment of anxiety disorders, depression, borderline personality, eating disorders, and schizophrenia. Course Level: This is a basic course. No prior experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 9-4; Hilton New York; fee: advance $160, on site $185; spaces available: 50.

COURSE 90:

MED-PSYCH DRUG-DRUG INTERACTIONS

Co-Directors: Scott C. Armstrong, M.D., Kelly L. Cozza, M.D. Faculty: David M. Benedek, M.D., Jessica R. Oesterheld, M.D., Neil B. Sandson, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand the relevant metabolic pharmacokinetic drug-drug interactions in the psychiatric and med-psych/consultation-liaison setting; (2) utilize tables, the Internet, and other relevant resources to apply the principles taught in this course to his/her own clinical practice; and (3) anticipate drug-drug interactions that may contribute to reduced drug effectiveness and/or side effects. Course Level: This is an intermediate course. Participants should have basic knowledge of Medicare and pharmacology. This is a revision of a course given last year. Wed., May 5, 9-4; Hilton New York; fee: advance $160, on site $185; spaces available: 150.

COURSE 91:

PSYCHIATRY AND THE INTERNET

American Association for Technology and Psychiatry. Director: Robert S. Kennedy, M.A. Faculty: Thomas A.M. Kramer, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) recognize the power of the Internet as a resource for the practice of psychiatry; (2) review the technology of the Internet and how it impacts the clinician and educator of today; and (3) discuss current and future applications of the Internet for the practice of medicine and psychiatry. Course Level: This is a basic course. No prior experience or knowledge required. This is a revision of a course given last year. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 25.

COURSE 92:

THE CLINICAL APPLICATION OF CULTURAL PSYCHIATRY

Director: Wen-Shing Tseng, M.D. Faculty: J. David Kinzie, M.D., Keh-Ming Lin, M.D., Jon M. Streltzer, M.D., Joseph J. Westermeyer, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) understand cultural psychiatry and (2) be able to provide culturally competent care for patients of diverse populations, including culturally relevant assessment and treatment. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 25.

COURSE 93:

MEN SEXUALLY ABUSED AS BOYS: MEANINGS, CONSEQUENCES, AND TREATMENT

Director: Murray D. Schane, M.D. Faculty: Howard Fradkin, Ph.D., William Holmes, M.D., Kenneth Singer, M.S.W, Bill Burmester, M.A.. Educational Objective: At the conclusion of this course, the participant should be able to (1) summarize the prevalence and characteristics of male sexual abuse; (2) recognize the typical comorbid symptomatologies; (3) develop appropriately broad treatment plans; and (4) list the most effective psycho-pharmacological interventions. Course Level: This is a basic course. No prior experience or knowledge required. This is a revision of a course given last year. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 94:

DELIRIUM IN THE GENERAL HOSPITAL

Director: Peter J. Manos, M.D. Faculty: J.H. Atkinson Jr., M.D., William Breitbart, M.D., Edwin H. Cassem, M.D. Educational Objective: Delirium—an acute disturbance of consciousness, cognition, and behavior—is common in the general hospital. It is often a dangerous and frightening syndrome. The physician who can help manage delirium is appreciated by everyone involved: patient, family, nurses, and the surgeons and internists who refer the patient for consultation. Course Level: This is a intermediate course. Participants should have an M.D., with some clinical experience. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 40.

COURSE 95:

INTEGRATING PSYCHOTHERAPY AND PHARMACOTHERAPY

APA Committee on Psychotherapy by Psychiatrists.Director: Barton J. Blinder, M.D. Faculty: Bernard D. Beitman, M.D., Jerald Kay, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) identify neurobiological foundations and clinical essentials of integrating pharmacotherapy and psychotherapy in the treatment of specific psychiatric disorders; (2) recognize by case examples the special determinants that facilitate and inhibit alleviation of clinical symptoms and psychological conflict with pharmacotherapy and psychotherapy combined; and (3) distinguish in a practical way among and between the various ways in which medications and psychotherapy are combined. Course Level: This is a basic course. No experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 96:

STREET DRUGS AND MENTAL DISORDERS: OVERVIEW AND TREATMENT

Director: Wen-Shing Tseng, M.D. Faculty: Thomas Newton, M.D., Karen A Miotto, M.D. Educational Objective: At the conclusion of this course, the participant should be able to understand the issues and difficulties relating to the treatment of dual-diagnosis patients. The available pharmacological agents for treatment of dual-diagnosis patients and medication treatment for substance-dependence disorders will be covered. Additionally, participants will learn the harm-reduction versus the abstinence model for dual-diagnosis patients. Course Level: This is a basic course. No previous experience or knowledge is required. This is a revision of a course given last year. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 50.

COURSE 97:

I FOUND IT AT THE MOVIES: USING FILM CLIPS TO UNDERSTAND AND TEACH PSYCHIATRY

Director: Frederick W. Engstrom, M.D. Educational Objective: At the conclusion of this course, the participant should be able to (1) find suitable film clips for teaching; (2) access readily at least 30 clips suitable for teaching; (3) lead a discussion about psychiatric diagnosis using films clips; (4) teach boundary theory using film clips; and (5) recognize the limitations and strengths of films as vehicles for teaching. Course Level: This is a basic course. No previous experience or knowledge is required. Wed., May 5, 1-5; Hilton New York; fee: advance $100, on site $130; spaces available: 100. A similar course on this topic will be offered on Sun., May 2, 8-12. See Course 18 for details.